| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965895 | Vaccine | 2013 | 6 Pages |
Abstract
rHA GLA/SE was well tolerated and immunogenic in healthy adults, and GLA/SE substantially improved the serum antibody response. rHA expressed using BEVS recombinant DNA platform technology represents a promising strategy for pandemic control.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
John J. Treanor, Brandon Essink, Steven Hull, Steven Reed, Ruvim Izikson, Peter Patriarca, Karen L. Goldenthal, Robert Kohberger, Lisa M. Dunkle,